NovoCure Limited logo

NVCR

NovoCure Limited

$73.56

Earnings Summary

Revenue
$122.18Mn
Net Profits
$-53.06Mn
Net Profit Margins
-43.43%

Highlights

Revenue:

NovoCure Limited’s revenue fell -11.17% since last year same period to $122.18Mn in the Q1 2023. On a quarterly growth basis, NovoCure Limited has generated -4.86% fall in its revenue since last 3-months.

Net Profits:

NovoCure Limited’s net profit fell -1041.83% since last year same period to $-53.06Mn in the Q1 2023. On a quarterly growth basis, NovoCure Limited has generated -42.24% fall in its net profits since last 3-months.

Net Profit Margins:

NovoCure Limited’s net profit margin fell -1185.42% since last year same period to -43.43% in the Q1 2023. On a quarterly growth basis, NovoCure Limited has generated -49.52% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the NovoCure Limited post its latest quarter earnings

EPS Estimate Current Quarter
-0.36
EPS Estimate Current Year
-0.36

Highlights

EPS Estimate Current Quarter:

NovoCure Limited’s earning per share (EPS) estimates for the current quarter stand at -0.36 - a -52.13% fall from last quarter’s estimates.

EPS Estimate Current Year:

NovoCure Limited’s earning per share (EPS) estimates for the current year stand at -0.36.

Key Ratios

Key ratios of the NovoCure Limited post its Q2 2023 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

NovoCure Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2023. This indicates that the NovoCure Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-05-04
-0.24
0
100%
2023-07-27
-0.36
0
100%